Why the study?
Traditional glucose monitoring methods involve invasive procedures causing discomfort and infection risk, prompting the need for non-invasive detection systems using IoT and cloud computing.
Does an IoT and cloud-based system using PPG signals accurately detect diabetes non-invasively?
Does an IoT and cloud-based system using PPG signals accurately detect diabetes non-invasively?
An IoT and cloud-based system utilizing PPG signals and machine learning can provide a non-invasive and accurate method for early-stage diabetes detection.
Answers are grounded in this paper and cite their sources.
Noninvasive IoT glucose monitoring may ease diabetes care; leaves open validation in larger trials before practice change.
Diabetes is a widespread chronic metabolic disorder that affects a substantial portion of the global population and requires diligent management and continuous medical supervision. Traditional glucose monitoring methods often involve invasive procedures that cause discomfort and increase the risk of infection. With the rapid advancements of the Internet of Things (IoT) and cloud computing, healthcare is evolving for early disease detection and personalized treatment solutions. The aim of this research is to develop a system based on the Internet of Things (IoT) for non-invasive diabetes detection using Photoplethysmography (PPG) signals. Our system leverages machine learning models, such as XGBoost, Random Forest, Logistic Regression, and SVM, to accurately classify diabetic patients using statistical features collected from PPG signals and metadata. To ensure model robustness, we employed a fivefold cross-validation approach. The hardware technology includes a portable, cost-effective system with a simple NIR sensor and a high-performing ESP32 module that minimizes user discomfort and ensures easy integration. Deployed on the Amazon Web Services (AWS) cloud platform, our system enables real-time data collection and analysis, providing users with a convenient web application for monitoring their diabetic status. The performance of the developed system has been tested with two different datasets: the PPG-BP dataset and the Mazandaran dataset, achieving 87.88% and 90% accuracy, respectively. The results demonstrate the potential of the designed system to revolutionize diabetes management by providing a non-invasive, accessible, and accurate solution for early-stage detection.
No takes yet. Share an insight, caveat, or question.
Ahmed et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: